miR-454 suppresses the proliferation and invasion of ovarian cancer by targeting E2F6.
Yunhe AnJun ZhangXiaoyan ChengBaoming LiYanjie TianXiaoli ZhangFangqi ZhaoPublished in: Cancer cell international (2020)
Taken together, these results highlight the role of miR-454 as a tumor suppressor in ovarian cancer cells by targeting E2F6, indicating that miR-454 may be a potential diagnostic biomarker and therapeutic target for ovarian cancer.